289 related articles for article (PubMed ID: 28578692)
21. Independent replication of a melanoma subtype gene signature and evaluation of its prognostic value and biological correlates in a population cohort.
Nsengimana J; Laye J; Filia A; Walker C; Jewell R; Van den Oord JJ; Wolter P; Patel P; Sucker A; Schadendorf D; Jönsson GB; Bishop DT; Newton-Bishop J
Oncotarget; 2015 May; 6(13):11683-93. PubMed ID: 25871393
[TBL] [Abstract][Full Text] [Related]
22. Genome-wide screen of promoter methylation identifies novel markers in melanoma.
Koga Y; Pelizzola M; Cheng E; Krauthammer M; Sznol M; Ariyan S; Narayan D; Molinaro AM; Halaban R; Weissman SM
Genome Res; 2009 Aug; 19(8):1462-70. PubMed ID: 19491193
[TBL] [Abstract][Full Text] [Related]
23. Integrated Genomic Classification of Melanocytic Tumors of the Central Nervous System Using Mutation Analysis, Copy Number Alterations, and DNA Methylation Profiling.
Griewank KG; Koelsche C; van de Nes JAP; Schrimpf D; Gessi M; Möller I; Sucker A; Scolyer RA; Buckland ME; Murali R; Pietsch T; von Deimling A; Schadendorf D
Clin Cancer Res; 2018 Sep; 24(18):4494-4504. PubMed ID: 29891723
[No Abstract] [Full Text] [Related]
24. Gene expression and promoter methylation of angiogenic and lymphangiogenic factors as prognostic markers in melanoma.
Monteiro AC; Muenzner JK; Andrade F; Rius FE; Ostalecki C; Geppert CI; Agaimy A; Hartmann A; Fujita A; Schneider-Stock R; Jasiulionis MG
Mol Oncol; 2019 Jun; 13(6):1433-1449. PubMed ID: 31069961
[TBL] [Abstract][Full Text] [Related]
25. Predicting the clinical outcome of melanoma using an immune-related gene pairs signature.
Meng L; He X; Zhang X; Zhang X; Wei Y; Wu B; Li W; Li J; Xiao Y
PLoS One; 2020; 15(10):e0240331. PubMed ID: 33031392
[TBL] [Abstract][Full Text] [Related]
26. A nine-gene signature predicting clinical outcome in cutaneous melanoma.
Brunner G; Reitz M; Heinecke A; Lippold A; Berking C; Suter L; Atzpodien J
J Cancer Res Clin Oncol; 2013 Feb; 139(2):249-58. PubMed ID: 23052696
[TBL] [Abstract][Full Text] [Related]
27. AIM1 and LINE-1 epigenetic aberrations in tumor and serum relate to melanoma progression and disease outcome.
Hoshimoto S; Kuo CT; Chong KK; Takeshima TL; Takei Y; Li MW; Huang SK; Sim MS; Morton DL; Hoon DS
J Invest Dermatol; 2012 Jun; 132(6):1689-97. PubMed ID: 22402438
[TBL] [Abstract][Full Text] [Related]
28. Prognostic molecular biomarkers for cutaneous malignant melanoma.
Tanaka R; Koyanagi K; Narita N; Kuo C; Hoon DS
J Surg Oncol; 2011 Sep; 104(4):438-46. PubMed ID: 21557225
[TBL] [Abstract][Full Text] [Related]
29. Is DNA ploidy of prognostic significance in stage I cutaneous melanoma?
Gattuso P; Reddy V; Solans E; Kathuria S; Aranha GV; Jacobs HK; Walloch J
Surgery; 1990 Oct; 108(4):702-8; discussion 708-9. PubMed ID: 2218882
[TBL] [Abstract][Full Text] [Related]
30. Identification of immune-related genes with prognostic significance in the microenvironment of cutaneous melanoma.
Qu Y; Zhang S; Zhang Y; Feng X; Wang F
Virchows Arch; 2021 May; 478(5):943-959. PubMed ID: 33179141
[TBL] [Abstract][Full Text] [Related]
31. Gene expression profiling of primary cutaneous melanoma and clinical outcome.
Winnepenninckx V; Lazar V; Michiels S; Dessen P; Stas M; Alonso SR; Avril MF; Ortiz Romero PL; Robert T; Balacescu O; Eggermont AM; Lenoir G; Sarasin A; Tursz T; van den Oord JJ; Spatz A;
J Natl Cancer Inst; 2006 Apr; 98(7):472-82. PubMed ID: 16595783
[TBL] [Abstract][Full Text] [Related]
32. Biomarkers: the useful and the not so useful--an assessment of molecular prognostic markers for cutaneous melanoma.
Gould Rothberg BE; Rimm DL
J Invest Dermatol; 2010 Aug; 130(8):1971-87. PubMed ID: 20555347
[TBL] [Abstract][Full Text] [Related]
33. Methylation levels of the "long interspersed nucleotide element-1" repetitive sequences predict survival of melanoma patients.
Sigalotti L; Fratta E; Bidoli E; Covre A; Parisi G; Colizzi F; Coral S; Massarut S; Kirkwood JM; Maio M
J Transl Med; 2011 May; 9():78. PubMed ID: 21615918
[TBL] [Abstract][Full Text] [Related]
34. MiRNAs as Potential Prognostic Biomarkers for Metastasis in Thin and Thick Primary Cutaneous Melanomas.
Valentini V; Zelli V; Gaggiano E; Silvestri V; Rizzolo P; Bucalo A; Calvieri S; Grassi S; Frascione P; Donati P; Soda G; Ottini L; Richetta AG
Anticancer Res; 2019 Aug; 39(8):4085-4093. PubMed ID: 31366492
[TBL] [Abstract][Full Text] [Related]
35. Gene signature of the metastatic potential of cutaneous melanoma: too much for too little?
Tímár J; Gyorffy B; Rásó E
Clin Exp Metastasis; 2010 Aug; 27(6):371-87. PubMed ID: 20177751
[TBL] [Abstract][Full Text] [Related]
36. DNA methylation-based immune response signature improves patient diagnosis in multiple cancers.
Jeschke J; Bizet M; Desmedt C; Calonne E; Dedeurwaerder S; Garaud S; Koch A; Larsimont D; Salgado R; Van den Eynden G; Willard Gallo K; Bontempi G; Defrance M; Sotiriou C; Fuks F
J Clin Invest; 2017 Aug; 127(8):3090-3102. PubMed ID: 28714863
[TBL] [Abstract][Full Text] [Related]
37. Integrative DNA methylome analysis of pan-cancer biomarkers in cancer discordant monozygotic twin-pairs.
Roos L; van Dongen J; Bell CG; Burri A; Deloukas P; Boomsma DI; Spector TD; Bell JT
Clin Epigenetics; 2016; 8():7. PubMed ID: 26798410
[TBL] [Abstract][Full Text] [Related]
38. Random forest-based modelling to detect biomarkers for prostate cancer progression.
Toth R; Schiffmann H; Hube-Magg C; Büscheck F; Höflmayer D; Weidemann S; Lebok P; Fraune C; Minner S; Schlomm T; Sauter G; Plass C; Assenov Y; Simon R; Meiners J; Gerhäuser C
Clin Epigenetics; 2019 Oct; 11(1):148. PubMed ID: 31640781
[TBL] [Abstract][Full Text] [Related]
39. The Expression Quantitative Trait Loci in Immune Pathways and their Effect on Cutaneous Melanoma Prognosis.
Vogelsang M; Martinez CN; Rendleman J; Bapodra A; Malecek K; Romanchuk A; Kazlow E; Shapiro RL; Berman RS; Krogsgaard M; Osman I; Kirchhoff T
Clin Cancer Res; 2016 Jul; 22(13):3268-80. PubMed ID: 26733611
[TBL] [Abstract][Full Text] [Related]
40. Identification of prognostic mRNAs in metastatic cutaneous melanoma.
Lee S; Suh HB; Choi SJ; Kang J; Kang JW; Kwon EJ; Kim HJ; Kim YH; Shin K
Melanoma Res; 2020 Dec; 30(6):543-547. PubMed ID: 33003118
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]